Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00114660
Status:
COMPLETED
Last Update Posted:
2009-03-06
First Post:
2005-06-16
Brief Title:
Cocoa Butter for Prevention of Stretch Marks
Sponsor:
American University of Beirut Medical Center
Organization:
American University of Beirut Medical Center
Study Overview
Official Title:
Topical Application of Cocoa Butter for Prevention of Striae Gravidarum
Status:
COMPLETED
Status Verified Date:
2007-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will check to see if using cocoa butter lotion on the belly breasts and thighs will help reduce the appearance of stretch marks in pregnancy Women entering the study will either receive a lotion containing cocoa butter with vitamin E or a lotion containing only vitamin E After delivery the study investigators will evaluate whether the women who used cocoa butter lotion were less likely to develop stretch marks
Detailed Description:
Primigravid women presenting for prenatal care in the first trimester will be recruited to participate in the study They will be randomly assigned to receive the study lotion a commercially available lotion containing cocoa butter with viatmin E a placebo lotion a lotion containing vitamin E but no cocoa butter Participants and investigators will be blinded to the lotion assignment
Women will be asked to apply a thin layer of the lotion to their abdomen breasts and thighs once daily until the date of delivery Participants will be recruited as early in their pregnancy as possible but will not be asked to start applying the lotion before 12 weeks of pregnancy Women presenting after 20 weeks of pregnancy will not be eligible to participate in the study The cocoa butter and placebo lotions have been made up to look smell and feel the same and will be provided to the participants in identical containers Women who have known hypersensitivity to cocoa butter or any of the components of the lotion will be excluded from the study
Participants will be assessed at study entry for presence of stretch marks Baseline information will be collected at that time including pre-pregnancy weight skin type and history of stretch marks in the mother or siblings Women will then be followed up monthly by telephone to assess compliance with the regimen and ensure that they are not developing skin reactions
Participants will be assessed for the development of stretch marks after delivery Women will also be asked to provide their own assessment of their skin condition in terms of presenceabsence of stretch marks and their severity
Women will be asked to apply a thin layer of the lotion to their abdomen breasts and thighs once daily until the date of delivery Participants will be recruited as early in their pregnancy as possible but will not be asked to start applying the lotion before 12 weeks of pregnancy Women presenting after 20 weeks of pregnancy will not be eligible to participate in the study The cocoa butter and placebo lotions have been made up to look smell and feel the same and will be provided to the participants in identical containers Women who have known hypersensitivity to cocoa butter or any of the components of the lotion will be excluded from the study
Participants will be assessed at study entry for presence of stretch marks Baseline information will be collected at that time including pre-pregnancy weight skin type and history of stretch marks in the mother or siblings Women will then be followed up monthly by telephone to assess compliance with the regimen and ensure that they are not developing skin reactions
Participants will be assessed for the development of stretch marks after delivery Women will also be asked to provide their own assessment of their skin condition in terms of presenceabsence of stretch marks and their severity
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| R588416 | None | None | None |